Dacogen decitabine: Final Phase III data

Final data from a double-blind, North American Phase III trial in 170

Read the full 123 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE